Dimensional Fund Advisors LP Voyager Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,105,044 shares of VYGR stock, worth $6.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,105,044

Previous 813,680 35.81%

Holding current value

$6.18 Million

Previous $6.44 Million 0.44%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$5.77 - $9.27 $1.68 Million - $2.7 Million	291,364 Added 35.81%	1,105,044 $6.46 Million
Q2 2024 Aug 09, 2024	SELL	$7.42 - $10.54 $2.17 Million - $3.08 Million	-291,875 Reduced 26.4%	813,680 $6.44 Million
Q1 2024 May 10, 2024	BUY	$7.15 - $10.84 $1.24 Million - $1.88 Million	173,324 Added 18.59%	1,105,555 $10.3 Million
Q4 2023 Feb 07, 2024	BUY	$6.28 - $8.81 $962,667 - $1.35 Million	153,291 Added 19.68%	932,231 $7.87 Million
Q3 2023 Nov 09, 2023	BUY	$7.55 - $11.25 $3.36 Million - $5.01 Million	445,545 Added 133.64%	778,940 $6.04 Million
Q2 2023 Aug 09, 2023	BUY	$6.94 - $13.99 $718,623 - $1.45 Million	103,548 Added 45.05%	333,395 $3.82 Million
Q1 2023 May 12, 2023	BUY	$6.0 - $10.78 $534,216 - $959,808	89,036 Added 63.23%	229,847 $1.77 Million
Q4 2022 Feb 09, 2023	BUY	$4.94 - $6.61 $231,132 - $309,268	46,788 Added 49.76%	140,811 $858,000
Q3 2022 Nov 10, 2022	SELL	$5.57 - $7.47 $91,364 - $122,530	-16,403 Reduced 14.85%	94,023 $556,000
Q2 2022 Aug 12, 2022	BUY	$4.82 - $10.09 $381,580 - $798,784	79,166 Added 253.25%	110,426 $652,000
Q4 2021 Feb 09, 2022	SELL	$2.47 - $5.55 $36,469 - $81,945	-14,765 Reduced 32.08%	31,260 $85,000
Q3 2021 Nov 12, 2021	SELL	$2.63 - $4.12 $16,555 - $25,935	-6,295 Reduced 12.03%	46,025 $121,000
Q2 2021 Aug 12, 2021	SELL	$3.94 - $5.44 $33,651 - $46,463	-8,541 Reduced 14.03%	52,320 $216,000
Q1 2021 May 14, 2021	BUY	$4.61 - $9.04 $59,694 - $117,058	12,949 Added 27.03%	60,861 $287,000
Q4 2020 Feb 25, 2021	BUY	$7.15 - $12.28 $342,570 - $588,359	47,912 New	47,912 $343,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $216M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Voyager Therapeutics, Inc. Transaction History